+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Automated and Closed Cell Therapy Processing Systems Market by Workflow, Type, Scale, and by Region - Global Forecast to 2022-2033

  • PDF Icon

    Report

  • 200 Pages
  • January 2023
  • Region: Global
  • Quintana Research and Consulting
  • ID: 5717256
The automated and closed cell therapy processing systems market size is estimated to be USD 712.45 million in 2022 and is expected to witness a CAGR of 21.92% during the forecast period 2023-2033. Rising popularity of regenerative medicines and cell therapies, and variety of advantages offered by automation technologies for the development of these therapies are some of the factors contributing to the market growth. Furthermore, rising partnerships and collaborations by key market players and increasing wide variety of systems are other factors supporting the market growth. However, lack of highly qualified workers is expected to hinder the growth.

Rising partnerships and collaborations by key market players is expected to fuel the market growth during the projected period. For instance, the partnership between Lonza and Cell Point stated their plan to use the Cocoon platform for the creation of T-cell-based therapeutics in June 2021. The goal of the project is to improve supply chain operations by providing a proof of concept for Point-of-Care (POC) production. Automated solutions are also anticipated to experience significant acceptance during the projection period as they can simplify quality control and improve analytical testing.

Increasing wide variety of systems is predicted to propel the market growth during the forecast period. These systems offer both partial automation and automated integrated workflow solutions. Additionally, these systems allow to continuously monitor the controlled therapeutic processing. The creation of numerous innovative treatments platforms is aided by these initiatives. The automated and closed cell therapy processing systems market is thus witnessing a variety of growth opportunities due to these characteristics.

Segmentation

By Workflow

The market is categorized into expansion, separation, fill- finish, cryopreservation, apheresis, and others. In 2022, the expansion segment accounted for the highest revenue share due to the fact availability of a significant number of products offered under this area. The expansion is also being fueled by an increase in partnerships among market participants for the adoption and use of the technologies provided under this segment. For instance, Angiocrine Bioscience has accelerated its cell therapy research by implementing Terumo BCT's quantum cell growth system. On the other hand, Separation workflow is anticipated to exhibit the quickest CAGR during the projection period. The cell separation procedure is used in a variety of cellular research, including molecular analysis, cellular genetic alteration, the creation of hybridomas, and other applications involving cell research and analysis. The market growth is expected to be accelerated by an increase in research activity for these applications at academic universities and other research environments. The workflow segment also includes apheresis, fill-finish, cryopreservation, and other processes in addition to expansion and separation. The workflows for cryopreservation and apheresis are also anticipated to develop significantly as a result of the public's growing knowledge and acceptance of regenerative medicine.

By Type

The market is divided into non-stem cell therapy and stem cell therapy. In the global market, the non-stem cell therapy segment accounted for the largest revenue share in 2022 owing to increase in the number of product launches for non-stem cell therapy applications. Additionally, the growth of non-stem cell therapies has attracted investment due to the success of CAR-T therapies, which is generating the segment's revenue. In order to create new regenerative medicines for the treatment of chronic diseases, companies are currently engaging in partnerships and collaborations. These studies are primarily concerned with non-stem cell applications, which is helping the non-stem cell therapy market to expand. Additionally, an increasing focus on cell and tissue-based engineering due to its enormous clinical potential is anticipated to expedite segment expansion during the projected period. Stem cell therapy market expansion is anticipated to be positively impacted by escalating research activities related to drug efficacy and disease knowledge and rising awareness of the therapeutic advantages offered by stem cell therapies.

By Scale

The market is segmented into commercial scale and pre-commercial/R&D scale. In 2022, the pre-commercial/R&D scale segment accounted for the largest revenue share owing to most of the companies are just launching their products for research. For instance, Cellares Inc. plans to release its automated cell treatment device in 2023. This fact is a major factor in the expansion of the pre-commercial/R&D scale segment. Additionally, the use of automated systems by research institutions as a result of the increase in cell therapy clinical trials is anticipated to speed up segment expansion. The implementation of automated systems has provided a number of advantages to laboratories and research facilities. Automated methods help in achieving high-speed processing and data reliability, states a recent study published on NCBI. The commercial-scale segment is anticipated to have the fastest CAGR over the projected period. Developing cell-therapy-based therapeutic platforms is being encouraged by the rising prevalence of chronic diseases including cancer. The market participants are also concentrating on cost optimization, which is helping the segment growth.

Regional Markets

In 2022, North America region accounted for the highest revenue in the automated and closed cell therapy processing systems market and is expected to maintain its dominance during the forecast period. This is attributed to the increasing technological usage for cell therapy processing and focus on high precision & production efficiency. Increasing investments from both market participants and research institutions are anticipated to be important for the growth of the region. Europe and Asia are expected to witness considerable growth rates during the predicted period. The region's market expansion is predicted to be fueled by a robust facility network and workforce in European nations. Recently, a number of completely automated platforms that can support the workflows of bioprocesses from beginning to end have been introduced across European nations.

Competitor Insights

Some of the key players operating in the automated and closed cell therapy processing systems market are ThermoGenesis Holdings, Inc., Lonza, Cytiva (Danaher Corp.), Terumo Corporation, Sartorius AG, BioSpherix, Ltd., Fresenius Kabi, Cellares, Inc., MiltenyiBiotec, and Thermo Fisher Scientific, Inc.

To achieve a competitive edge, these companies are implementing a variety of growth strategies. Strategic partnerships, alliances, and agreements with different businesses and research institutions are seen to be the main strategies used by companies in this sector.

For instance, Cytiva and Brooks Life Sciences decided to expand the automated cold chain's capabilities in February 2021. The companies are collaborating together to enhance the cryogenic cold chain elements of Cytiva's automated cold chain technology.

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including workflow, type, and scale from 2023 to 2033.

Segmentation: Automated and Closed Cell Therapy Processing Systems Market Report 2022 - 2033

Workflow (Revenue, USD Million), 2022 - 2033

  • Expansion
  • Separation
  • Fill- Finish
  • Cryopreservation
  • Apheresis
  • Others

Type (Revenue, USD Million), 2022 - 2033

  • Non-Stem Cell Therapy
  • Stem Cell Therapy

Scale (Revenue, USD Million), 2022 - 2033

  • Commercial Scale
  • Pre-commercial/R&D Scale

By Region (Revenue, USD Million), 2022 - 2033

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Framework
1.3.1. Research Models
1.3.1.1. Bottom-up Approach
1.3.1.2. Top-down Approach
1.3.1.3. Data Triangulation
1.3.2. Data Analysis
1.3.2.1. Data Validation
1.3.2.2. Market Size Estimation
1.3.2.3. Market Forecast Model

2. Introduction: Automated and Closed Cell Therapy Processing Systems

3. Executive Summary

4. Market Dynamics
4.1. Market Drivers
4.1.1. Driver 1
4.1.2. Driver 2
4.1.3. Driver 3
4.1.4. Driver 4
4.2. Market Restraint
4.2.1. Restraint 1
4.2.2. Restraint 2
4.2.3. Restraint 3
4.3. Market Opportunities
4.3.1. Opportunity 1
4.3.2. Opportunity 2
4.3.3. Opportunity 3
4.4. Market Trends
4.4.1. Trend 1
4.4.2. Trend 2
4.4.3. Trend 3
4.5. Market Challenges
4.5.1. Challenge 1
4.5.2. Challenge 2
4.5.3. Challenge 3

5. Market Environment Analysis
5.1. Porter’s 5 Forces Analysis
5.2. PESTEL Analysis
5.3. SWOT Analysis

6. COVID-19 Impact Analysis: Automated and Closed Cell Therapy Processing Systems Market

7. Market Analysis by Workflow
7.1. Expansion
7.1.1. Expansion Market Forecast, 2022-2033 (USD Million)
7.2. Separation
7.2.1. Separation Market Forecast, 2022-2033 (USD Million)
7.3. Fill- Finish
7.3.1. Fill- Finish Market Forecast, 2022-2033 (USD Million)
7.4. Cryopreservation
7.4.1. Cryopreservation Market Forecast, 2022-2033 (USD Million)
7.5. Apheresis
7.5.1. Apheresis Market Forecast, 2022-2033 (USD Million)
7.6. Others
7.6.1. Others Market Forecast, 2022-2033 (USD Million)

8. Market Analysis by Type
8.1. Non-Stem Cell Therapy
8.1.1. Non-Stem Cell Therapy Market Forecast, 2022-2033 (USD Million)
8.2. Stem Cell Therapy
8.2.1. Stem Cell Therapy Market Forecast, 2022-2033 (USD Million)

9. Market Analysis by Scale
9.1. Commercial Scale
9.1.1. Commercial Scale Market Forecast, 2022-2033 (USD Million)
9.2. Pre-commercial/R&D Scale
9.2.1. Pre-commercial/R&D Scale Market Forecast, 2022-2033 (USD Million)

8. Regional Market Analysis
8.1. Regional Market Trends Analysis

9. North America Automated and Closed Cell Therapy Processing Systems Market
9.1. North America Automated and Closed Cell Therapy Processing Systems Market
9.1.1. North America Market Size and Forecast, 2022-2033 (USD Million)
9.1.1.1. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
9.1.1.2. Market Size and Forecast by Type, 2022-2033 (USD Million)
9.1.1.3. Market Size and Forecast by Scale, 2022-2033 (USD Million)
9.2. U.S. Automated and Closed Cell Therapy Processing Systems Market
9.2.1. U.S. Market Size and Forecast, 2022-2033 (USD Million)
9.2.1.1. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
9.2.1.2. Market Size and Forecast by Type, 2022-2033 (USD Million)
9.2.1.3. Market Size and Forecast by Scale, 2022-2033 (USD Million)
9.3. Canada Automated and Closed Cell Therapy Processing Systems Market
9.3.1. Canada Market Size and Forecast, 2022-2033 (USD Million)
9.3.1.1. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
9.3.1.2. Market Size and Forecast by Type, 2022-2033 (USD Million)
9.3.1.3. Market Size and Forecast by Scale, 2022-2033 (USD Million)

10. Europe Automated and Closed Cell Therapy Processing Systems Market
10.1. Europe Automated and Closed Cell Therapy Processing Systems Market
10.1.1. Europe Market Size and Forecast, 2022-2033 (USD Million)
10.1.1.1. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
10.1.1.2. Market Size and Forecast by Type, 2022-2033 (USD Million)
10.1.1.3. Market Size and Forecast by Scale, 2022-2033 (USD Million)
10.2. Germany Automated and Closed Cell Therapy Processing Systems Market
10.2.1. Germany Market Size and Forecast, 2022-2033 (USD Million)
10.2.1.1. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
10.2.1.2. Market Size and Forecast by Type, 2022-2033 (USD Million)
10.2.1.3. Market Size and Forecast by Scale, 2022-2033 (USD Million)
10.3. UK Automated and Closed Cell Therapy Processing Systems Market
10.3.1. UK Market Size and Forecast, 2022-2033 (USD Million)
10.3.1.1. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
10.3.1.2. Market Size and Forecast by Type, 2022-2033 (USD Million)
10.3.1.3. Market Size and Forecast by Scale, 2022-2033 (USD Million)
10.4. France Automated and Closed Cell Therapy Processing Systems Market
10.4.1. France Market Size and Forecast, 2022-2033 (USD Million)
10.4.1.1. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
10.4.1.2. Market Size and Forecast by Type, 2022-2033 (USD Million)
10.4.1.3. Market Size and Forecast by Scale, 2022-2033 (USD Million)
10.5. Spain Automated and Closed Cell Therapy Processing Systems Market
10.5.1. Spain Market Size and Forecast, 2022-2033 (USD Million)
10.5.1.1. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
10.5.1.2. Market Size and Forecast by Type, 2022-2033 (USD Million)
10.5.1.3. Market Size and Forecast by Scale, 2022-2033 (USD Million)
10.6. Italy Automated and Closed Cell Therapy Processing Systems Market
10.6.1. Italy Market Size and Forecast, 2022-2033 (USD Million)
10.6.1.1. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
10.6.1.2. Market Size and Forecast by Type, 2022-2033 (USD Million)
10.6.1.3. Market Size and Forecast by Scale, 2022-2033 (USD Million)
10.7. Rest of Europe Automated and Closed Cell Therapy Processing Systems Market
10.7.1. Rest of Europe Market Size and Forecast, 2022-2033 (USD Million)
10.7.1.1. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
10.7.1.2. Market Size and Forecast by Type, 2022-2033 (USD Million)
10.7.1.3. Market Size and Forecast by Scale, 2022-2033 (USD Million)

11. Asia Pacific Automated and Closed Cell Therapy Processing Systems Market
11.1. Asia Pacific Automated and Closed Cell Therapy Processing Systems Market
11.1.1. Asia Pacific Market Size and Forecast, 2022-2033 (USD Million)
11.1.1.1. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
11.1.1.2. Market Size and Forecast by Type, 2022-2033 (USD Million)
11.1.1.3. Market Size and Forecast by Scale, 2022-2033 (USD Million)
11.2. Japan Automated and Closed Cell Therapy Processing Systems Market
11.2.1. Japan Market Size and Forecast, 2022-2033 (USD Million)
11.2.1.1. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
11.2.1.2. Market Size and Forecast by Type, 2022-2033 (USD Million)
11.2.1.3. Market Size and Forecast by Scale, 2022-2033 (USD Million)
11.3. China Automated and Closed Cell Therapy Processing Systems Market
11.3.1. China Market Size and Forecast, 2022-2033 (USD Million)
11.3.1.1. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
11.3.1.2. Market Size and Forecast by Type, 2022-2033 (USD Million)
11.3.1.3. Market Size and Forecast by Scale, 2022-2033 (USD Million)
11.4. India Automated and Closed Cell Therapy Processing Systems Market
11.4.1. India Market Size and Forecast, 2022-2033 (USD Million)
11.4.1.1. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
11.4.1.2. Market Size and Forecast by Type, 2022-2033 (USD Million)
11.4.1.3. Market Size and Forecast by Scale, 2022-2033 (USD Million)
11.5. South Korea Automated and Closed Cell Therapy Processing Systems Market
11.5.1. South Korea Market Size and Forecast, 2022-2033 (USD Million)
11.5.1.1. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
11.5.1.2. Market Size and Forecast by Type, 2022-2033 (USD Million)
11.5.1.3. Market Size and Forecast by Scale, 2022-2033 (USD Million)
11.6. Australia Automated and Closed Cell Therapy Processing Systems Market
11.6.1. Australia Market Size and Forecast, 2022-2033 (USD Million)
11.6.1.1. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
11.6.1.2. Market Size and Forecast by Type, 2022-2033 (USD Million)
11.6.1.3. Market Size and Forecast by Scale, 2022-2033 (USD Million)
11.7. Rest of Asia Pacific Automated and Closed Cell Therapy Processing Systems Market
11.7.1. Rest of Asia Pacific Market Size and Forecast, 2022-2033 (USD Million)
11.7.1.1. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
11.7.1.2. Market Size and Forecast by Type, 2022-2033 (USD Million)
11.7.1.3. Market Size and Forecast by Scale, 2022-2033 (USD Million)

12. Latin America Automated and Closed Cell Therapy Processing Systems Market
12.1. Latin America Automated and Closed Cell Therapy Processing Systems Market
12.1.1. Latin America Market Size and Forecast, 2022-2033 (USD Million)
12.1.1.1. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
12.1.1.2. Market Size and Forecast by Type, 2022-2033 (USD Million)
12.1.1.3. Market Size and Forecast by Scale, 2022-2033 (USD Million)
12.2. Brazil Automated and Closed Cell Therapy Processing Systems Market
12.2.1. Brazil Market Size and Forecast, 2022-2033 (USD Million)
12.2.1.1. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
12.2.1.2. Market Size and Forecast by Type, 2022-2033 (USD Million)
12.2.1.3. Market Size and Forecast by Scale, 2022-2033 (USD Million)
12.3. Mexico Automated and Closed Cell Therapy Processing Systems Market
12.3.1. Mexico Market Size and Forecast, 2022-2033 (USD Million)
12.3.1.1. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
12.3.1.2. Market Size and Forecast by Type, 2022-2033 (USD Million)
12.3.1.3. Market Size and Forecast by Scale, 2022-2033 (USD Million)
12.4. Argentina Automated and Closed Cell Therapy Processing Systems Market
12.4.1. Argentina Market Size and Forecast, 2022-2033 (USD Million)
12.4.1.1. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
12.4.1.2. Market Size and Forecast by Type, 2022-2033 (USD Million)
12.4.1.3. Market Size and Forecast by Scale, 2022-2033 (USD Million)
12.5. Rest of Latin America Automated and Closed Cell Therapy Processing Systems Market
12.5.1. Rest of Latin America Market Size and Forecast, 2022-2033 (USD Million)
12.5.1.1. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
12.5.1.2. Market Size and Forecast by Type, 2022-2033 (USD Million)
12.5.1.3. Market Size and Forecast by Scale, 2022-2033 (USD Million)

13. MEA Automated and Closed Cell Therapy Processing Systems Market
13.1. MEA Automated and Closed Cell Therapy Processing Systems Market
13.1.1. MEA Market Size and Forecast, 2022-2033 (USD Million)
13.1.1.1. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
13.1.1.2. Market Size and Forecast by Type, 2022-2033 (USD Million)
13.1.1.3. Market Size and Forecast by Scale, 2022-2033 (USD Million)
13.2. GCC Automated and Closed Cell Therapy Processing Systems Market
13.2.1. GCC Market Size and Forecast, 2022-2033 (USD Million)
13.2.1.1. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
13.2.1.2. Market Size and Forecast by Type, 2022-2033 (USD Million)
13.2.1.3. Market Size and Forecast by Scale, 2022-2033 (USD Million)
13.3. South Africa Automated and Closed Cell Therapy Processing Systems Market
13.3.1. South Africa Market Size and Forecast, 2022-2033 (USD Million)
13.3.1.1. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
13.3.1.2. Market Size and Forecast by Type, 2022-2033 (USD Million)
13.3.1.3. Market Size and Forecast by Scale, 2022-2033 (USD Million)
13.4. Rest of MEA Automated and Closed Cell Therapy Processing Systems Market
13.4.1. Rest of MEA Market Size and Forecast, 2022-2033 (USD Million)
13.4.1.1. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
13.4.1.2. Market Size and Forecast by Type, 2022-2033 (USD Million)
13.4.1.3. Market Size and Forecast by Scale, 2022-2033 (USD Million)

14. Competitor Analysis
14.1. Market Share Analysis, 2022
14.2. Major Recent Developments, 2019-2022

15. Company Profiles
15.1. ThermoGenesis Holdings, Inc.
15.1.1. Company Snapshot
15.1.2. Company Overview
15.1.3. Financial Analysis
15.1.4. Product Benchmarking
15.1.5. Recent Developments
15.2. Lonza
15.2.1. Company Snapshot
15.2.2. Company Overview
15.2.3. Financial Analysis
15.2.4. Product Benchmarking
15.2.5. Recent Developments
15.3. Cytiva (Danaher Corp.)
15.3.1. Company Snapshot
15.3.2. Company Overview
15.3.3. Financial Analysis
15.3.4. Product Benchmarking
15.3.5. Recent Developments
15.4. Terumo Corporation
15.4.1. Company Snapshot
15.4.2. Company Overview
15.4.3. Financial Analysis
15.4.4. Product Benchmarking
15.4.5. Recent Developments
15.5. Sartorius AG
15.5.1. Company Snapshot
15.5.2. Company Overview
15.5.3. Financial Analysis
15.5.4. Product Benchmarking
15.5.5. Recent Developments
15.6. BioSpherix, Ltd.
15.6.1. Company Snapshot
15.6.2. Company Overview
15.6.3. Financial Analysis
15.6.4. Product Benchmarking
15.6.5. Recent Developments
15.7. Fresenius Kabi
15.7.1. Company Snapshot
15.7.2. Company Overview
15.7.3. Financial Analysis
15.7.4. Product Benchmarking
15.7.5. Recent Developments
15.8. Cellares, Inc
15.8.1. Company Snapshot
15.8.2. Company Overview
15.8.3. Financial Analysis
15.8.4. Product Benchmarking
15.8.5. Recent Developments
15.9. MiltenyiBiotec
15.9.1. Company Snapshot
15.9.2. Company Overview
15.9.3. Financial Analysis
15.9.4. Product Benchmarking
15.9.5. Recent Developments
15.10. Thermo Fisher Scientific, Inc.
15.10.1. Company Snapshot
15.10.2. Company Overview
15.10.3. Financial Analysis
15.10.4. Product Benchmarking
15.10.5. Recent Developments
15.11. Company 11
15.11.1. Company Snapshot
15.11.2. Company Overview
15.11.3. Financial Analysis
15.11.4. Product Benchmarking
15.11.5. Recent Developments
15.12. Company 12
15.12.1. Company Snapshot
15.12.2. Company Overview
15.12.3. Financial Analysis
15.12.4. Product Benchmarking
15.12.5. Recent Developments
15.13. Company 13
15.13.1. Company Snapshot
15.13.2. Company Overview
15.13.3. Financial Analysis
15.13.4. Product Benchmarking
15.13.5. Recent Developments
15.14. Company 14
15.14.1. Company Snapshot
15.14.2. Company Overview
15.14.3. Financial Analysis
15.14.4. Product Benchmarking
15.14.5. Recent Developments
15.15. Company 15
15.15.1. Company Snapshot
15.15.2. Company Overview
15.15.3. Financial Analysis
15.15.4. Product Benchmarking
15.15.5. Recent Developments

16. Conclusion

17. Recommendations

Companies Mentioned

A selection of companies mentioned in this report includes:

  • ThermoGenesis Holdings Inc.
  • Lonza
  • Cytiva (Danaher Corp.)
  • Terumo Corporation
  • Sartorius AG
  • BioSpherix Ltd.
  • Fresenius Kabi
  • Cellares Inc.
  • MiltenyiBiotec
  • Thermo Fisher Scientific Inc.